- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Merck Ratings Report.
Merck has 'all the momentum right now,' Lebenthal Asset Management CEO Jim Lebenthal said.
Rising drugs prices are a concern to Donald Trump but we can't let development of 'wonder drugs' slow in the health care sector, Cramer said.